Mr. Speaker, that is exactly the question at the heart of tonight's debate. This is exactly why we are calling on the federal government to do some planning, to do some management of this file which has been so badly lacking.
The member is right. It is an issue about generic drugs. It is an issue about dealing with the entire supply chain and managing its integrity, not just for today, not just in the middle of a crisis, but frankly for years down the road.
This is why we are having this debate. I wish the government would answer this question because it deserves an answer and in fact is what triggered tonight's debate.